First nine months of the year with 1% sales growth at constant exchange rates, significant impact of COVID-19 pandemicGlobeNewsWire • 10/15/20
Roche to launch laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patientsGlobeNewsWire • 10/13/20
Forbion Portfolio Company, Enterprise Therapeutics’ First-in-Class TMEM16A Potentiator Program for Treatment of Cystic Fibrosis and Other Respiratory Diseases Acquired by RocheBusiness Wire • 10/07/20
Enterprise Therapeutics’ First-in-Class TMEM16A potentiator program for treatment of cystic fibrosis and other respiratory diseases acquired by RocheBusiness Wire • 10/07/20
Judge Rules Tamiflu-Maker Hoffman-La Roche Must Answer Whistleblower Fraud ClaimsPRNewsWire • 10/01/20
Genentech Presents New 2-Year Data for Evrysdi (risdiplam) in Infants With Type 1 Spinal Muscular Atrophy (SMA)Business Wire • 09/28/20
Roche presents new 2-year data for Evrysdi (risdiplam) in infants with Type 1 spinal muscular atrophy (SMA)GlobeNewsWire • 09/28/20
Roche presents new data from multiple Phase III studies of Tecentriq in triple-negative breast cancer at ESMO Virtual Congress 2020GlobeNewsWire • 09/19/20
Genentech Presents New Data From Multiple Phase III Studies of Tecentriq in Triple-Negative Breast Cancer at ESMO Virtual Congress 2020Business Wire • 09/19/20
Roche says its Actemra drug reduces the severity of COVID-19 in hospitalised patientsInvezz • 09/18/20
Roche receives positive CHMP opinion for Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancerGlobeNewsWire • 09/18/20
Shares of Roche gain as it says arthritis drug can lessen need for ventilators in COVID-19 patientsMarket Watch • 09/18/20
Roche launches new quantitative antibody test to measure SARS-CoV-2 antibodies, to support the evaluation of vaccinesGlobeNewsWire • 09/18/20